HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund P Cap EUR

Register to Unlock Ratings
Performance History30/04/2024
Growth of 1,000 (GBP) Advanced Graph
HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund P Cap EUR
Fund26.3-11.1-10.46.8-7.6
+/-Cat-----
+/-B’mrk-----
 
Key Stats
NAV
16/05/2024
 EUR 118.97
Day Change -0.15%
Morningstar Category™ Other Equity
ISIN LU1540962211
Fund Size (Mil)
16/05/2024
 USD 24.11
Share Class Size (Mil)
16/05/2024
 EUR 0.16
Max Initial Charge 3.00%
Ongoing Charge
19/02/2024
  2.27%
Investment Objective: HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund P Cap EUR
The investment objective of the Sub-Fund is to achieve long-term capital growth. The goal is to generate a value trend that exceeds the performance of the NASDAQ Biotechnology Index (the “Benchmark”). No guarantee can be given that the investment objective will be achieved.
Returns
Trailing Returns (GBP)16/05/2024
YTD-3.08
3 Years Annualised-3.08
5 Years Annualised3.30
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
Ivo Staijen
31/12/2011
Inception Date
24/01/2018
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USD-
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund P Cap EUR31/03/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock100.000.00100.00
Bond0.000.000.00
Property0.000.000.00
Cash0.000.000.00
Other0.000.000.00
Top 5 Regions%
United States74.03
Europe - ex Euro15.23
United Kingdom3.76
Eurozone3.16
Canada2.58
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Zealand Pharma A/SHealthcareHealthcare5.90
Vertex Pharmaceuticals IncHealthcareHealthcare5.84
Regeneron Pharmaceuticals IncHealthcareHealthcare5.76
Amgen IncHealthcareHealthcare5.67
Blueprint Medicines CorpHealthcareHealthcare4.73
HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund P Cap EUR
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures